Your browser doesn't support javascript.
loading
Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.
Kallen, Joerg; Izaac, Aude; Chau, Suzanne; Wirth, Emmanuelle; Schoepfer, Joseph; Mah, Robert; Schlapbach, Achim; Stutz, Stefan; Vaupel, Andrea; Guagnano, Vito; Masuya, Keiichi; Stachyra, Therese-Marie; Salem, Bahaa; Chene, Patrick; Gessier, Francois; Holzer, Philipp; Furet, Pascal.
Afiliación
  • Kallen J; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Izaac A; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Chau S; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Wirth E; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Schoepfer J; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Mah R; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Schlapbach A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Stutz S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Vaupel A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Guagnano V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Masuya K; Present address: Peptidream Inc., Menguro, Tokyo, Japan.
  • Stachyra TM; Disease Area Oncology, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Salem B; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Chene P; Disease Area Oncology, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Gessier F; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Holzer P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Furet P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
ChemMedChem ; 14(14): 1305-1314, 2019 07 17.
Article en En | MEDLINE | ID: mdl-31066983
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Proteínas de Ciclo Celular / Proteínas Proto-Oncogénicas c-mdm2 / Compuestos Heterocíclicos Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Proteínas de Ciclo Celular / Proteínas Proto-Oncogénicas c-mdm2 / Compuestos Heterocíclicos Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Alemania